Verve Therapeutics Inc (VERV)
4.79
-0.59
(-10.97%)
USD |
NASDAQ |
Nov 15, 16:00
4.79
0.00 (0.00%)
After-Hours: 16:36
Verve Therapeutics Total Return Level: 5.38 for Nov. 14, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 14, 2024 | 5.38 |
November 13, 2024 | 5.79 |
November 12, 2024 | 6.41 |
November 11, 2024 | 6.42 |
November 08, 2024 | 6.31 |
November 07, 2024 | 6.36 |
November 06, 2024 | 6.41 |
November 05, 2024 | 6.38 |
November 04, 2024 | 6.05 |
November 01, 2024 | 5.93 |
October 31, 2024 | 5.73 |
October 30, 2024 | 5.79 |
October 29, 2024 | 5.99 |
October 28, 2024 | 5.94 |
October 25, 2024 | 5.97 |
October 24, 2024 | 5.72 |
October 23, 2024 | 5.54 |
October 22, 2024 | 5.69 |
October 21, 2024 | 5.55 |
October 18, 2024 | 5.65 |
October 17, 2024 | 5.46 |
October 16, 2024 | 5.60 |
October 15, 2024 | 5.59 |
October 14, 2024 | 5.03 |
October 11, 2024 | 4.67 |
Date | Value |
---|---|
October 10, 2024 | 4.60 |
October 09, 2024 | 4.57 |
October 08, 2024 | 4.52 |
October 07, 2024 | 4.79 |
October 04, 2024 | 5.00 |
October 03, 2024 | 4.72 |
October 02, 2024 | 4.80 |
October 01, 2024 | 4.79 |
September 30, 2024 | 4.84 |
September 27, 2024 | 4.98 |
September 26, 2024 | 4.96 |
September 25, 2024 | 4.77 |
September 24, 2024 | 4.95 |
September 23, 2024 | 5.02 |
September 20, 2024 | 5.19 |
September 19, 2024 | 5.38 |
September 18, 2024 | 5.51 |
September 17, 2024 | 5.39 |
September 16, 2024 | 5.42 |
September 13, 2024 | 5.50 |
September 12, 2024 | 5.65 |
September 11, 2024 | 5.87 |
September 10, 2024 | 5.61 |
September 09, 2024 | 5.62 |
September 06, 2024 | 5.595 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
4.40
Minimum
Aug 14 2024
73.99
Maximum
Sep 10 2021
22.23
Average
17.59
Median
Jul 06 2022
Total Return Level Benchmarks
Ardelyx Inc | 4.71 |
Biomarin Pharmaceutical Inc | 65.60 |
Sage Therapeutics Inc | 5.37 |
ALX Oncology Holdings Inc | 1.33 |
Immuneering Corp | 1.94 |